Comparative parallel assessment of a transfer device in reducing 5-fluorouracil environmental contamination inside positive air pressure isolators.
The environmental contamination of the antineoplastic drugs circuit, due to the centralization of preparation and the increased number of the patients treated, brought about a new occupational hazard: the chronic exposure to low doses of antineoplastic drugs. The rationalization of the hospital budgets imposes a meticulous assessment of the devices available for the preparation, in order to justify their interest, even their cost. A prospective comparative study with parallel arms was led inside the Pharmacy of the Institut de Cancerologie de la Loire in order to evaluate the Spike Swan®, a transfer device. The aim was to assess the Spike Swan® effectiveness. The antineoplastic drugs environmental contamination within the isolators is considered as a potential starting point for a larger dissemination of cytotoxic products. Therefore, the primary endpoint was the surface contamination level with 5-fluorouracil and the comparator was the standard preparation technique using needles and aeration needles. This study did not show significant effectiveness for the Spike Swan® in reducing surface contamination. Nevertheless, this device could be used to prepare large volumes and to secure occasional handlers, because it is easy to handle.
Forges
Fabien
F
Department of Clinical Pharmacology and Innovation, CHU St Etienne, St Etienne, France. fabien.forges@chu-st-etienne.fr
Simoens
Xavier
X
Chauvin
Franck
F
D000964:Antimetabolites, Antineoplastic / Q000032:analysis*; D004339:Drug Compounding / Q000295:instrumentation / Q000379:methods; D004784:Environmental Monitoring / Q000379:methods; D004866:Equipment Contamination / Q000517:prevention & control*; D005472:Fluorouracil / Q000032:analysis*; D006761:Hospitals; D006801:Humans; D009339:Needles; D016273:Occupational Exposure / Q000517:prevention & control; D010607:Pharmacy Service, Hospital / Q000379:methods; D011482:Protective Devices
D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil